Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
Abstract Background Colorectal cancer (CRC) screening is the most efficient strategy to reduce disease-related mortality. Frequent aberrant DNA methylation is known to occur in selected genes and early during CRC development, which has emerged as a new epigenetic biomarker for early detection of CRC...
Main Authors: | Tae Jeong Oh, Hyun Il Oh, Yang Yei Seo, Dongjun Jeong, Changjin Kim, Hyoun Woo Kang, Yoon Dae Han, Hyun Cheol Chung, Nam Kyu Kim, Sungwhan An |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Clinical Epigenetics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13148-017-0426-3 |
Similar Items
-
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
by: Zhang W, et al.
Published: (2021-04-01) -
Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
by: Guodong Zhao, et al.
Published: (2020-06-01) -
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
by: Yoon Dae Han, et al.
Published: (2019-03-01) -
Hormonelle Regulation von WNT1 und SDC1 in humanen Mammakarzinomzellen
by: Benad, Peggy
Published: (2012) -
COLLISION MODEL SIMPLIFICATIONS IN THE DYNAMIC ANALYSIS WITH THE SDC METHOD
by: PiotrALEKSANDROWICZ
Published: (2020-06-01)